Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-338281
Filing Date
2025-12-31
Accepted
2025-12-31 16:01:27
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B3 d98130d424b3.htm 424B3 788393
2 GRAPHIC g98130g00t12.jpg GRAPHIC 166530
3 GRAPHIC g98130g00t13.jpg GRAPHIC 142465
4 GRAPHIC g98130g00t14.jpg GRAPHIC 185518
5 GRAPHIC g98130g00t15.jpg GRAPHIC 112602
6 GRAPHIC g98130g00t16.jpg GRAPHIC 142019
7 GRAPHIC g98130g00t17.jpg GRAPHIC 137042
8 GRAPHIC g98130g00t18.jpg GRAPHIC 127985
9 GRAPHIC g98130g00t19.jpg GRAPHIC 124951
10 GRAPHIC g98130g00z03.jpg GRAPHIC 34224
11 GRAPHIC g98130g00z10.jpg GRAPHIC 142811
12 GRAPHIC g98130g01t21.jpg GRAPHIC 108139
13 GRAPHIC g98130g02t21.jpg GRAPHIC 135467
  Complete submission text file 0001193125-25-338281.txt   2727164
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-292175 | Film No.: 251617435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)